
Celerion
Investors Count
6Funding, Valuation & Revenue
5 Fundings
Celerion's latest funding round was a Acq - Fin - II for on October 13, 2022.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/13/2022 | Acq - Fin - II | 5 | ||||
11/14/2017 | Acq - Fin | |||||
10/29/2014 | Recap | |||||
1/5/2010 | Unattributed VC | |||||
Other Investors |
Date | 10/13/2022 | 11/14/2017 | 10/29/2014 | 1/5/2010 | |
|---|---|---|---|---|---|
Round | Acq - Fin - II | Acq - Fin | Recap | Unattributed VC | Other Investors |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 5 |
Celerion Investors
6 Investors
Celerion has 6 investors. H.I.G. Capital invested in Celerion's Acq - Fin - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/13/2022 | 10/13/2022 | 1 Acq - Fin - II | Asset/Investment Management | Florida | ||
Private Equity | New York | |||||
Private Equity | New York | |||||
Venture Capital | Massachusetts | |||||
Venture Capital | California |
First funding | 10/13/2022 | ||||
|---|---|---|---|---|---|
Last Funding | 10/13/2022 | ||||
Investor | |||||
Rounds | 1 Acq - Fin - II | ||||
Board Seats | |||||
Type | Asset/Investment Management | Private Equity | Private Equity | Venture Capital | Venture Capital |
Location | Florida | New York | New York | Massachusetts | California |
Compare Celerion to Competitors

Parexel operates as a clinical research organization (CRO) specializing in biopharmaceutical services. The company offers services from Phase I to IV clinical development, including clinical trial design, regulatory strategy, patient engagement, and market access consulting. It was founded in 1982 and is based in Raleigh, North Carolina.

Premier Research is a clinical research organization that provides services including clinical research and development, product development, regulatory consulting, and late phase research. The company specializes in various therapeutic areas such as oncology, hematology, rare diseases, and cell and gene therapy. It was founded in 1989 and is based in Morrisville, North Carolina.

Alira Health is a global healthcare firm that provides consulting and clinical services within the life sciences sector. The company offers services including regulatory consulting, clinical research, biometrics analysis, and supply chain management (CMC) to support the development and market access of healthcare products. Alira Health serves the biotech, medtech, and pharmaceutical industries. It was founded in 1999 and is based in Framingham, Massachusetts.

Komodo Health focuses on providing data-driven insights in the healthcare sector. The company offers a software platform that analyzes a variety of data to provide insights for various healthcare stakeholders. These insights aim to assist life sciences, patient advocacy, healthcare practitioners, and payers in their efforts to support patient care and manage costs. It was founded in 2014 and is based in New York, New York.

HITLAB is a healthcare innovation and technology lab focused on research and advisory services related to health delivery through digital health efficacy. The company provides services such as business strategy, research, scientific studies, and user experience design. HITLAB also offers a professional development platform for executives and an accelerator program for startups. It was founded in 1998 and is based in New York, New York.
Care Access is a health research company that focuses on clinical research and the development of new medical treatments. The company offers services such as conducting clinical research studies, providing health screenings, and facilitating community engagement in health research. Care Access primarily serves the healthcare and clinical research sectors. It was founded in 2016 and is based in Boston, Massachusetts.
Loading...

